• Genoa in the News

Genoa Healthcare® Chief Executive Officer provides industry outlook in Chain Drug Review article

Feb 2nd, 2024

In the health care industry in 2024, pharmacy teams will continue to play a critical role in providing care in areas with limited access to pharmacy services.

Genoa Healthcare Chief Executive Officer Todd Gustin discussed the expanded role of the pharmacist and what that means for improving access to care in Chain Drug Review’s recent industry outlook article.

“Genoa will continue filling gaps in care for [medically underserved] populations, focusing on providing care in areas where access to pharmacy services is limited,” said Gustin. “Often called pharmacy deserts, these are areas where patients experience significant barriers to accessing their needed medications due to their geographic location and distance from a pharmacy.”

You can read the full article here.

Let’s connect

Want to learn more about offering Genoa pharmacy services to your consumers? Fill out the form below and we’ll be in touch.

"*" indicates required fields

Name*
Does your organization currently partner with Genoa?*
This field is for validation purposes and should be left unchanged.

Recent Posts


  • Art Celebration
  • Consumer Stories
  • People-first Pharmacy Care
Genoa Art Celebration participant heals through art, helps others after losing daughter to substance use disorder

Content warning: This post discusses mental illness and substance use. Please call the Suicide and Crisis Lifeline at 988, the Substance Abuse and Mental Health Services Administration’s National Helpline at...

  • Consumer Stories
  • Partnering with Genoa
  • People-first Pharmacy Care
“It was really emotional”: Genoa pharmacist turned director reunites with consumer

When Jeannie Barrett, PharmD, transitioned from her role as a pharmacist to director of pharmacy operations for Genoa Healthcare, she wondered if she’d get the chance to see her consumers...

  • Clinical Insights
  • Treatment
RELEXXII®: 6 things to know about the new FDA-approved treatment for ADHD

Staying on top of new medication options for your consumers living with ADHD can be difficult. Learn more about the new FDA-approved medication RELEXXII®, a long-acting formulation of methylphenidate. 1....

  • Partnering with Genoa
  • People-first Pharmacy Care
3 reasons to transition your pharmacy to Genoa Healthcare

Having a pharmacy right within your clinic offers a lot of benefits: it can break down barriers to care, improve consumer and provider satisfaction and drive better outcomes for the...